AKT

You have access
Combined Targeting of AKT and mTOR Synergistically Inhibits Formation of Primary Colorectal Carcinoma Tumouroids In Vitro: A 3D Tumour Model for Pre-therapeutic Drug Screening
DOMINIK NÖRZ, CHRISTINA S. MULLINS, DANIEL J. SMIT, MICHAEL LINNEBACHER, GRITH HAGEL, ALP MIRDOGAN, JACQUELINE SIEKIERA, PATRICK EHM, JAKOB R. IZBICKI, ANDREAS BLOCK, OLE THASTRUP and MANFRED JÜCKER

Anticancer Research May 2021, 41 (5) 2257-2275; DOI: https://doi.org/10.21873/anticanres.15002
You have access
Lenvatinib Inhibits AKT/NF-κB Signaling and Induces Apoptosis Through Extrinsic/Intrinsic Pathways in Non-small Cell Lung Cancer
YU-CHANG LIU, BO-HAN HUANG, JING-GUNG CHUNG, WEI-LIN LIU, FEI-TING HSU and SONG-SHEI LIN

Anticancer Research January 2021, 41 (1) 123-130; DOI: https://doi.org/10.21873/anticanres.14757
You have access
3EZ, 20Ac-ingenol-induced Apoptosis in Chemoresistant Cancers With Cyclin D1 Accumulation
SHOHEI MIYATA, TOMONORI NAKAMURA and SUSUMU KITANAKA

Anticancer Research November 2020, 40 (11) 6237-6246; DOI: https://doi.org/10.21873/anticanres.14644
You have access
PGC-1α Regulates Cell Proliferation and Invasion via AKT/GSK-3β/β-catenin Pathway in Human Colorectal Cancer SW620 and SW480 Cells
SEONG-HOON YUN and JOO-IN PARK

Anticancer Research February 2020, 40 (2) 653-664; DOI: https://doi.org/10.21873/anticanres.13995
You have access
COUP-TFII Knock-down Promotes Proliferation and Invasion in Colorectal Cancer Cells via Activation of Akt Pathway and Up-regulation of FOXC1
SEONG-HOON YUN, SANG-HEUM HAN and JOO-IN PARK

Anticancer Research January 2020, 40 (1) 177-190; DOI: https://doi.org/10.21873/anticanres.13939
You have access
Akt Pathway Inhibition of the Solenopsin Analog, 2-Dodecylsulfanyl-1,-4,-5,-6-tetrahydropyrimidine
NNE E. UKO, OSMAN F. GÜNER, J. PHILLIP BOWEN and DIANE F. MATESIC

Anticancer Research October 2019, 39 (10) 5329-5338; DOI: https://doi.org/10.21873/anticanres.13725
You have access
Virtual Screening of 1,4-Naphthoquinone Derivatives for Inhibition of a Key Cancer Signaling Protein, AKT1 Kinase
MOHD REHAN and MAGED MOSTAFA

Anticancer Research July 2019, 39 (7) 3823-3833; DOI: https://doi.org/10.21873/anticanres.13532
You have access
Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial–Mesenchymal Transition of Thyroid Carcinoma Cells
SI HYOUNG KIM, JUN GOO KANG, CHUL SIK KIM, SUNG-HEE IHM, MOON GI CHOI and SEONG JIN LEE

Anticancer Research November 2018, 38 (11) 6339-6352; DOI: https://doi.org/10.21873/anticanres.12992
You have access
Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells
MAKOTO ISONO, AKINORI SATO, TAKAKO ASANO, KAZUKI OKUBO and TOMOHIKO ASANO

Anticancer Research October 2018, 38 (10) 5709-5716; DOI: https://doi.org/10.21873/anticanres.12908
You have access
Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin
YOON JUNG KIM, HYO-JEONG HWANG, JUN GOO KANG, CHUL SIK KIM, SUNG-HEE IHM, MOON GI CHOI and SEONG JIN LEE

Anticancer Research June 2018, 38 (6) 3515-3525; DOI: https://doi.org/10.21873/anticanres.12623

Main menu

User menu

Search

AKT

Pages